1,123
Views
40
CrossRef citations to date
0
Altmetric
Review Article

The potential use of rabies virus glycoprotein-derived peptides to facilitate drug delivery into the central nervous system: a mini review

, &
Pages 379-385 | Received 20 Jun 2016, Accepted 09 Aug 2016, Published online: 31 Aug 2016

References

  • Yan XZ, Mohankumar PS, Dietzschold B, et al. The rabies virus glycoprotein determines the distribution of different rabies virus strains in the brain. J Neurovirol 2002;8:345–52.
  • Son S, Hwang DW, Singha K, et al. RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain. J Control Release 2011;155:18–25.
  • Fu AL, Wang YL, Zhan LP, Zhou RM. Targeted delivery of proteins into the central nervous system mediated by rabies virus glycoprotein-derived peptide. Pharm Res 2012;29:1562–9.
  • Fu AL, Zhao ZZ, Gao FY, Zhang MM. Cellular uptake mechanism and therapeutic utility of a novel peptide in targeted-delivery of proteins into neuronal cells. Pharm Res 2013;30:2108–17.
  • Zhang E, Fu A. A new strategy for specific imaging of neural cells based on peptide-conjugated gold nanoclusters. Int J Nanomed 2015;10:2115–24.
  • Chen W, Zhan C, Gu B, et al. Targeted brain delivery of itraconazole via RVG29 anchored nanoparticles. J Drug Target 2011;19:228–34.
  • Liu Y, Huang R, Han L, et al. Brain-targeting gene delivery and cellular internalisation mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles. Biomaterials 2009;30:4195–202.
  • Lafon M. Rabies virus receptors. J NeuroVirol 2005;11:82–7.
  • Kumar P, Wu H, McBride JL, et al. Transvascular delivery of small interfering RNA to the central nervous system. Nature 2007;448:39–43.
  • Lycke E, Tsiang H. Rabies virus-infection of cultured rat sensory neurons. J Virol 1987;61:2733–41.
  • Lewis P, Fu YG, Lentz TL. Rabies virus entry at the neuromuscular junction in nerve-muscle cocultures. Muscle Nerve 2000;23:720–30.
  • Cherian S, Singh R, Singh A. Rabies glycoprotein: a benefit to the virus, us or both? J Vet Sci 2015;1:1–9.
  • Hislop JN, Islam TA, Eleftheriadou I, et al. Rabies virus envelope glycoprotein targets lentiviral vectors to the axonal retrograde pathway in motor neurons. J Biol Chem 2014;289:16148–63.
  • Kwon EJ, Lasiene J, Jacobson BE, et al. Targeted nonviral delivery vehicles to neural progenitor cells in the mouse subventricular zone. Biomaterials 2010;31:2417–24.
  • Etessami R, Conzelmann KK, Fadai-Ghotbi B, et al. Spread and pathogenic characteristics of a G-deficient rabies virus recombinant: an in vitro and in vivo study. J Gen Virol 2000;81:2147–53.
  • Lentz T, Burrage t, Smith A, et al. Is the acetylcholine receptor a rabies virus receptor? Science 1982;215:182–4.
  • Lentz TL. Structure-function-relationships of curaremimetic neurotoxin loop-2 and of a structurally similar segment of rabies virus glycoprotein in their interaction with the nicotinic acetylcholine-receptor. Biochemistry 1991;30:10949–57.
  • Zhan C, Yan Z, Xie C, Lu W. Loop 2 of ophiophagus hannah toxin b binds with neuronal nicotinic acetylcholine receptors and enhances intracranial drug delivery. Mol Pharm 2010;7:1940–7.
  • Gastka M, Horvath J, Lentz TL. Rabies virus binding to the nicotinic acetylcholine receptor alpha subunit demonstrated by virus overlay protein binding assay. J Gen Virol 1996;77:2437–40.
  • Sajjanar B, Saxena S, Bisht D, et al. Effect of nicotinic acetylcholine receptor alpha 1 (nAChRα1) peptides on rabies virus infection in neuronal cells. Neuropeptides 2015;54:59–64.
  • Vigerelli H, Sciani JM, Jared C, et al. Bufotenine is able to block rabies virus infection in BHK-21 cells. J Venom Anim Toxins Incl Trop Dis 2014;20:45.
  • Wunner WH, Reagan KJ, Koprowski H. Characterization of saturable binding sites for rabies virus. J Virol 1984;50:691–7.
  • Castaneda-Castellanos DR, Castellanos JE, Hurtado H. Differential use of the nicotinic receptor by rabies virus based upon substrate origin. J Neurovirol 2002;8:150–4.
  • Reagan KJ, Wunner WH. Rabies virus interaction with various cell lines is independent of the acetylcholine receptor. Arch Virol 1985;84:277–82.
  • Shytle RD, Mori T, Townsend K, et al. Cholinergic modulation of microglial activation by alpha-7 nicotinic receptors. J Neurochem 2004;89:337–43.
  • Abbruscato TJ, Lopez SP, Mark KS, et al. Nicotine and cotinine modulate cerebral microvascular permeability and protein expression of ZO-1 through nicotinic acetylcholine receptors expressed on brain endothelial cells. J Pharm Sci 2002;91:2525–38.
  • Petrov KA, Girard E, Nikitashina AD, et al. Schwann cells sense and control acetylcholine spill-over at the neuromuscular junction by alpha 7 nicotinic receptors and butyrylcholinesterase. J Neurosci 2014;34:11870–83.
  • Paratcha G, Ledda F, Ibáñez CF. The neural cell adhesion molecule NCAM Is an alternative signaling receptor for GDNF family ligands. Cell 2003;113:867–79.
  • Hubschmann MV, Skladchikova G, Bock E, Berezin V. Neural cell adhesion molecule function is regulated by metalloproteinase-mediated ectodomain release. J Neurosci Res 2005;80:826–37.
  • Chipman PH, Franz CK, Nelson A, et al. Neural cell adhesion molecule is required for stability of reinnervated neuromuscular junctions. Eur J Neurosci2010;31:238–49.
  • Thoulouze M, Lafage M, Schachner M, et al. The neural cell adhesion molecule is a receptor for rabies virus. J Virol 1998;72:7181–90.
  • Tuffereau C, Benejean J, Roque-Alfonso A, et al. Neuronal cell surface molecules mediate specific binding to rabies virus glycoprotein expressed by a recombinant baculovirus on the surfaces of lepidopteran cells. J Virol 1998;17:7250–9.
  • Tuffereau C, Schmidt K, Langevin C, et al. The rabies virus glycoprotein receptor p75NTR is not essential for rabies virus infection. J Virol 2007;81:13622–30.
  • Gotti C, Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol 2004;74:363–96.
  • Dunckley T, Lukas RJ. Nicotinic modulation of gene expression in SH-SY5Y neuroblastoma cells. Brain Res 2006;1116:39–49.
  • Albuquerque E, Alkondon M, Pereira E, et al. Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterisation and modulation of synaptic function. J Pharm Exp Ther 1997;280:1117–36.
  • Haddadian EJ, Cheng MH, Coalson RD, et al. In silico models for the human alpha 4 beta 2 nicotinic acetylcholine receptor. J Phys Chem B 2008;112:13981–90.
  • Quik M, Wonnacott S. α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease. Pharmacol Rev 2011;63:938–66.
  • Paterson D, Nordberg A. Neuronal nicotinic receptors in the human brain. Prog Neurobiol 2000;61:75–111.
  • Gotti C, Zoli M, Clementi F. Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol Sci 2006;27:482–91.
  • Warpman U, Friberg L, Gillespie A, et al. Regulation of nicotinic receptor subtypes following chronic nicotinic agonist exposure in M10 and SH-SY5Y neuroblastoma cells. J Neurochem 1998;70:2028–37.
  • Posadas I, Lopez-Hernandez B, Cena V. Nicotinic receptors in neurodegeneration. Curr Neuropharm 2013;11:298–314.
  • Navaneetham D, Penn A, Howard J, ContiFine BM. Expression of the alpha 7 subunit of the nicotinic acetylcholine receptor in normal and myasthenic human thymuses. Cell Mol Biol 1997;43:433–42.
  • De Simone R, Ajmone-Cat MA, Carnevale D, Minghetti L. Activation of alpha 7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E-2 in rat microglial cultures. J Neuroinflammation 2005;2:4.
  • Maus ADJ, Pereira EFR, Karachunski PI, et al. Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors. Mol Pharmacol 1998;54:779–88.
  • Grando SA, Zelickson BD, Kist DA, et al. Keratinocyte muscarinic acetylcholine receptors: immunolocalization and partial characterization. J Invest Dermatol 1995;104:95–100.
  • Grando SA, Horton RM, Mauro TM, et al. Activation of keratinocyte nicotinic cholinergic receptors stimulates calcium influx and enhances cell differentiation. J Invest Dermatol 1996;107:412–8.
  • Conti-Fine BM, Navaneetham D, Lei S, Maus ADJ. Neuronal nicotinic receptors in non-neuronal cells: new mediators of tobacco toxicity? Eur J Pharmacol 2000;393:279–94.
  • Egleton RD, Brown KC, Dasgupta P. Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. Trends Pharmacol Sci 2008;29:151–8.
  • Sharma G, Vijayaraghavan S. Nicotinic receptor signaling in nonexcitable cells. J Neurobiol 2002;53:524–34.
  • Court JA, Martin-Ruiz C, Graham A, Perry E. Nicotinic receptors in human brain: topography and pathology. J Chem Neuroanat 2000;20:281–98.
  • Wang Y, Pereira EFR, Maus ADJ, et al. Human bronchial epithelial and endothelial cells express a7 nicotinic acetylcholine receptors. Mol Pharmacol 2001;60:1201–9.
  • Fischer U, Reinhardt S, Albuquerque EX, Maelicke A. Expression of functional alpha 7 nicotinic acetylcholine receptor during mammalian muscle development and denervation. Eur J Neurosci 1999;11:2856–64.
  • Kuo Y, Lucero L, Michaels J, et al. Differential expression of nicotinic acetylcholine receptor subunits in foetal and neonatal mouse thymus. J Neuroimmunol 2002;130:140–54.
  • Nguyen VT, Ndoye A, Grando SA. Novel human α9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus Vulgaris autoimmunity. Am J Pathol 2000;157:1377–91.
  • Albuquerque EX, Pereira EFR, Alkondon M, Rogers SW. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev 2009;89:73–120.
  • Galzi JL, Changeux JP. Neuronal nicotinic receptors: molecular organization and regulations. Neuropharmacology 1995;34:563–82.
  • Castellanos JE, Castaneda DR, Velandia AE, Hurtado H. Partial inhibition of the in vitro infection of adult mouse dorsal root ganglion neurons by rabies virus using nicotinic antagonists. Neurosci Lett 1997;229:198–200.
  • Lentz TL, Fu YG, Lewis P. Rabies virus infection of IMR-32 human neuroblastoma cells and effect of neurochemical and other agents. Antiviral Res 1997;35:29–39.
  • Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: an overview – structure, regulation, and clinical implications. Neurobiol Dis 2004;16:1–13.
  • Wilhelm I, Fazakas C, Krizbai IA. In vitro models of the blood-brain barrier. Acta Neurobiol Exp 2011;71:113–28.
  • Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008;57:178–201.
  • Lentz TL. Rabies virus binding to an acetylcholine receptor alpha-subunit peptide. J Mol Recognit 1990;3:82–8.
  • Mazarakis ND, Azzouz M, Rohll JB, et al. Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum Mol Genet 2001;10:2109–21.
  • St. Pierre CA, Leonard D, Corvera S, et al. Antibodies to cell surface proteins redirect intracellular trafficking pathways. Exp Mol Pathol 2011;91:723–32.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.